Skip to main content

Market Overview

UPDATE: Bank of America Reiterates on Acadia Healthcare as Initial Guide Sets Base for Growth


In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Acadia Healthcare (NASDAQ: ACHC), and raised the price target from $56.00 to $58.00.

In the report, Bank of America noted, “Our rating reflects our view that organic growth through bed additions/conversions supplemented by acquisitions will drive the fastest earnings growth in our coverage universe. Meanwhile, the expected rapid growth should allow the company to leverage its costs and close the margin gap between its current margin and its long-term 20% margin target. The management team has a proven track record in this industry executing on this type of strategy.”

Acadia Healthcare closed on Thursday at $51.89.

Latest Ratings for ACHC

Mar 2021Credit SuisseMaintainsNeutral
Mar 2021Raymond JamesMaintainsStrong Buy
Nov 2020Credit SuisseMaintainsNeutral

View More Analyst Ratings for ACHC
View the Latest Analyst Ratings


Related Articles (ACHC)

View Comments and Join the Discussion!

Posted-In: Bank of America Kevin FischbeckAnalyst Color Price Target Analyst Ratings

Latest Ratings

SELFAegis CapitalInitiates Coverage On6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at